Segui
Tia L Kauffman
Tia L Kauffman
Altri nomiTia L Neely
Kaiser Permanente
Email verificata su kpchr.org
Titolo
Citata da
Citata da
Anno
COVID-19 vaccination coverage among pregnant women during pregnancy—eight integrated health care organizations, United States, December 14, 2020–May 8, 2021
H Razzaghi
MMWR. Morbidity and Mortality Weekly Report 70, 2021
1822021
Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010–2011 …
MG Thompson, DK Li, P Shifflett, LZ Sokolow, JR Ferber, S Kurosky, ...
Clinical infectious diseases 58 (4), 449-457, 2014
1812014
Clinical sequencing exploratory research consortium: accelerating evidence-based practice of genomic medicine
RC Green, KAB Goddard, GP Jarvik, LM Amendola, PS Appelbaum, ...
The American Journal of Human Genetics 98 (6), 1051-1066, 2016
1692016
Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study
MR Hart, BB Biesecker, CL Blout, KD Christensen, LM Amendola, ...
Genetics in Medicine 21 (5), 1100-1110, 2019
1452019
Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy
EM Webber, TL Kauffman, E O’Connor, KAB Goddard
BMC cancer 15, 1-12, 2015
1132015
“Is it worth knowing?” Focus group participants’ perceived utility of genomic preconception carrier screening
JL Schneider, KAB Goddard, J Davis, B Wilfond, TL Kauffman, JA Reiss, ...
Journal of Genetic Counseling 25 (1), 135-145, 2016
552016
Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer
DS Cross, AK Rahm, TL Kauffman, J Webster, AQ Le, ...
Genetics in Medicine 15 (12), 933-940, 2013
532013
Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators
JL Schneider, J Davis, TL Kauffman, JA Reiss, C McGinley, K Arnold, ...
Genetics in Medicine 18 (2), 152-161, 2016
502016
Why patients decline genomic sequencing studies: experiences from the CSER consortium
LM Amendola, JO Robinson, R Hart, S Biswas, K Lee, BA Bernhardt, ...
Journal of Genetic Counseling 27, 1220-1227, 2018
482018
Preconception carrier screening by genome sequencing: results from the clinical laboratory
S Punj, Y Akkari, J Huang, F Yang, A Creason, C Pak, A Potter, ...
The American Journal of Human Genetics 102 (6), 1078-1089, 2018
482018
Reasons for declining preconception expanded carrier screening using genome sequencing
MJ Gilmore, J Schneider, JV Davis, TL Kauffman, MC Leo, K Bergen, ...
Journal of genetic counseling 26 (5), 971-979, 2017
482017
Predictors of breastfeeding initiation and maintenance in an integrated healthcare setting
ML Henninger, SA Irving, TL Kauffman, SK Kurosky, K Rompala, ...
Journal of Human Lactation 33 (2), 256-266, 2017
472017
A weight-loss intervention program designed for Mexican–American women: Cultural adaptations and results
NM Lindberg, VJ Stevens, S Vega-López, TL Kauffman, MR Calderón, ...
Journal of immigrant and minority health 14, 1030-1039, 2012
452012
Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing
TL Kauffman, BS Wilfond, GP Jarvik, MC Leo, FL Lynch, JA Reiss, ...
Contemporary clinical trials 53, 100-105, 2017
342017
Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing
P Himes, TL Kauffman, KR Muessig, LM Amendola, JS Berg, ...
Genetics in Medicine 19 (7), 803-808, 2017
322017
Generating a taxonomy for genetic conditions relevant to reproductive planning
DM Korngiebel, CK McMullen, LM Amendola, JS Berg, JV Davis, ...
American Journal of Medical Genetics Part A 170 (3), 565-573, 2016
312016
KRAS Testing and Epidermal Growth Factor Receptor Inhibitor Treatment for Colorectal Cancer in Community Settings
J Webster, TL Kauffman, HS Feigelson, PA Pawloski, AA Onitilo, ...
Cancer epidemiology, biomarkers & prevention 22 (1), 91-101, 2013
282013
Cancer Health Assessments Reaching Many (CHARM): a clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations
KF Mittendorf, TL Kauffman, LM Amendola, KP Anderson, BB Biesecker, ...
Contemporary clinical trials 106, 106432, 2021
272021
Patient perspectives on the use of categories of conditions for decision making about genomic carrier screening results
SA Kraft, CK McMullen, KM Porter, TL Kauffman, JV Davis, JL Schneider, ...
American journal of medical genetics Part A 176 (2), 376-385, 2018
262018
The NextGen Study: patient motivation for participation in genome sequencing for carrier status
TL Kauffman, SA Irving, MC Leo, MJ Gilmore, P Himes, CK McMullen, ...
Molecular genetics & genomic medicine 5 (5), 508-515, 2017
262017
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20